|
1
|
McCaffrey J, Lennon R and Webb NJ: The
non-immunosuppressive management of childhood nephrotic syndrome.
Pediatr Nephrol. 31:1383–1402. 2016. View Article : Google Scholar
|
|
2
|
Zhao X, Hwang DY and Kao HY: The role of
glucocorticoid receptors in podocytes and nephrotic syndrome. Nucl
Receptor Res. 5:1013232018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tian X, Kim JJ, Monkley SM, Gotoh N,
Nandez R, Soda K, Inoue K, Balkin DM, Hassan H, Son SH, et al:
Podocyte-associated talin1 is critical for glomerular filtration
barrier maintenance. J Clin Invest. 124:1098–1113. 2014. View Article : Google Scholar
|
|
4
|
Andolino TP and Reid-Adam J: Nephrotic
syndrome. Pediatr Rev. 36:117–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ranganathan S: Pathology of
podocytopathies causing nephrotic syndrome in children. Front
Pediatr. 4:322016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noris M and Remuzzi G: Non-muscle myosins
and the podocyte. Clin Kidney J. 5:94–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reiser J and Altintas MM: Podocytes.
F1000Res. 5:F10002016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu T, Xie C, Bhaskarabhatla M, Yan M,
Leone A, Chen SS, Zhou XJ, Putterman C and Mohanet C: Excreted
urinary mediators in an animal model of experimental immune
nephritis with potential pathogenic significance. Arthritis Rheum.
56:949–959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Teramoto K, Negoro N, Kitamoto K, Iwai T,
Iwao H, Okamura M and Miura K: Microarray analysis of glomerular
gene expression in murine lupus nephritis. J Pharmacol Sci.
106:56–67. 2018. View Article : Google Scholar
|
|
10
|
Lin Z, Gong Q, Zhou Z, Zhang W, Liao S,
Liu Y, Yan XX, Pan X, Lin S and Li X: Increased plasma CXCL16
levels in patients with chronic kidney diseases. Eur J Clin Invest.
41:836–845. 2011. View Article : Google Scholar
|
|
11
|
Gong Q, Wu F, Pan X, Yu J, Li Y, Lu T, Li
X and Lin Z: Soluble C-X-C CXC motif chemokine ligand 16 levels are
increased in gout patients. Clin Biochem. 45:1368–1373. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garcia GE, Truong LD, Li P, Zhang P,
Johnson RJ, Wilson CB and Feng L: Inhibition of CXCL16 attenuates
inflammatory and progressive phases of anti-glomerular basement
membrane antibody-associated glomerulonephritis. Am J Pathol.
170:1485–1496. 2017. View Article : Google Scholar
|
|
13
|
Riedel JH, Paust HJ, Turner JE, Tittel AP,
Krebs C, Disteldorf E, Wegscheid C, Tiegs G, Velden J, Mittrücker
HW, et al: Immature renal dendritic cells recruit regulatory
CXCR6(+) invariant natural killer T cells to attenuate crescentic
GN. J Am Soc Nephrol. 23:1987–2000. 2012. View Article : Google Scholar
|
|
14
|
Liu B, Zhang H, Tan X, Yang D, Lv Z, Jiang
H, Lu J, Baiyun R and Zhang Z: GSPE reduces lead-induced oxidative
stress by activating the Nrf2 pathway and suppressing miR153 and
GSK-3βn rat kidney. Oncotarget. 8:42226–42237. 2017. View Article : Google Scholar
|
|
15
|
Zheng X, Li S, Li J, Lv Y, Wang X, Wu P,
Yang Q, Tang Y, Liu Y and Zhang Z: Hexavalent chromium induces
renal apoptosis and autophagy via disordering the balance of
mitochondrial dynamics in rats. Ecotoxicol Environ Saf.
204:1110612020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang D, Yang Q, Fu N, Li S, Han B, Liu Y,
Tang Y, Guo X, Lv Z and Zhang Z: Hexavalent chromium induced heart
dysfunction via Sesn2-mediated impairment of mitochondrial function
and energy supply. Chemosphere. 264((Pt 2)): 1285472021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu N and Malemud CJ: Extracellular
signal-regulated kinase: A regulator of cell growth, inflammation,
chondrocyte and bone cell receptor-mediated gene expression. Int J
Mol Sci. 20:37922019. View Article : Google Scholar
|
|
18
|
Kehat I and Molkentin JD: Extracellular
signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac
hypertrophy. Ann N Y Acad Sci. 1188:96–102. 2010. View Article : Google Scholar
|
|
19
|
Liu F, Yang X, Geng M and Huang M:
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer
therapy. Acta Pharm Sin B. 8:552–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boulton TG, Nye SH, Robbins DJ, Ip NY,
Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH
and Yancopoulos GD: ERKs: A family of protein-serine/threonine
kinases that are activated and tyrosine phosphorylated in response
to insulin and NGF. Cell. 65:663–675. 1991. View Article : Google Scholar
|
|
21
|
Lakshmanan AP, Thandavarayan RA, Watanabe
K, Sari FR, Meilei H, Giridharan VV, Sukumaran V, Soetikno V,
Arumugam S, Suzuki K and Kodama M: Modulation of AT-1R/MAPK cascade
by an olmesartan treatment attenuates diabetic nephropathy in
streptozotocin-induced diabetic mice. Mol Cell Endocrinol.
348:104–111. 2012. View Article : Google Scholar
|
|
22
|
Zhou D, Zhou M, Wang Z, Fu Y, Jia M, Wang
X, Liu M, Zhang Y, Sun Y, Zhou Y, et al: Progranulin alleviates
podocyte injury via regulating CAMKK/AMPK-mediated autophagy under
diabetic conditions. J Mol Med (Berl). 97:1507–1520. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Liang K, Zhen J, Zhou M, Wang X,
Wang Z, Wei X, Zhang Y, Sun Y, Zhou Z, et al: Sirt6 deficiency
exacerbates podocyte injury and proteinuria through targeting notch
signaling. Nat Commun. 8:4132017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Wang Z, Li Q, Yu L, Zhu Y, Wang J
and Sun S: OxLDL promotes podocyte migration by regulating CXCL16,
ADAM10 and ACTN4. Mol Med Rep. 22:1976–1984. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–8. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao G, Wang X and Wang J, Zu L, Cheng G,
Hao M, Sun X, Xue Y, Lu J and Wang J: CXCL16/CXCR6 chemokine
signaling mediates breast cancer progression by pERK1/2-dependent
mechanisms. Oncotarget. 6:14165–14178. 2015. View Article : Google Scholar
|
|
27
|
Xiao XC, Gu YL, Chen SX, Wang GJ and Yuan
L: Effect of SHIP-1 on invasion, migration and PI3K-AKT signaling
pathway of leukemic cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
26:324–329. 2018.(In Chinese).
|
|
28
|
Liu Y: New insights into
epithelial-mesenchymal transition in kidney fibrosis. J Am Soc
Nephrol. 21:212–222. 2010. View Article : Google Scholar
|
|
29
|
Kang YS, Li Y, Dai C, Kiss LP, Wu C and
Liu Y: Inhibition of integrin-linked kinase blocks podocyte
epithelial-mesenchymal transition and ameliorates proteinuria.
Kidney Int. 78:363–373. 2010. View Article : Google Scholar
|
|
30
|
Wang L, Sun S, Zhou A, Yao X and Wang Y:
oxLDL-induced lipid accumulation in glomerular podocytes: Role of
IFN-gamma, CXCL16, and ADAM10. Cell Biochem Biophys. 70:529–538.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kwoh C, Shannon MB, Miner JH and Shaw A:
Pathogenesis of nonimmune glomerulopathies. Annu Rev Pathol.
1:349–374. 2006. View Article : Google Scholar
|
|
32
|
Takeda T, McQuistan T, Orlando RA and
Farquhar MG: Loss of glomerular foot processes is associated with
uncoupling of podocalyxin from the actin cytoskeleton. J Clin
Invest. 108:289–301. 2001. View
Article : Google Scholar
|
|
33
|
Bergwall L, Wallentin H, Elvin J, Liu P,
Boi R, Sihlbom C, Hayes K, Wright D, Haraldsoon B, Nystrom J and
Buvall L: Amplification of the melanocortin-1 receptor in nephrotic
syndrome identifies a target for podocyte cytoskeleton
stabilization. Sci Rep. 8:157312018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng R, Deng Y, Chen Y, Fan J, Zhang M,
Zhong Y, Zhu R and Wang L: Astragaloside IV attenuates complement
membranous attack complex induced podocyte injury through the MAPK
pathway. Phytother Res. 26:892–898. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Hua T, Li J, Zheng L, Wang Y, Xu
M and Qi G: CXCL16 is activated by p-JNK and is involved in
H2O2-induced HK-2 cell injury via p-ERK signaling. Am J Transl Res.
10:3723–3732. 2018.PubMed/NCBI
|
|
36
|
Ying Q and Wu G: Molecular mechanisms
involved in podocyte EMT and concomitant diabetic kidney diseases:
An update. Ren Fail. 39:474–483. 2017. View Article : Google Scholar
|
|
37
|
Boini KM, Xia M, Xiong J, Li C, Payne LP
and Li PL: Implication of CD38 gene in podocyte
epithelial-to-mesenchymal transition and glomerular sclerosis. J
Cell Mol Med. 16:1674–1685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Patrakka J and Tryggvason K: Molecular
make-up of the glomerular filtration barrier. Biochem Biophys Res
Commun. 396:164–169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Welsh GI and Saleem MA: The podocyte
cytoskeleton-key to a functioning glomerulus in health and disease.
Nat Rev Nephrol. 8:14–21. 2011. View Article : Google Scholar
|
|
40
|
Ha TS: Roles of adaptor proteins in
podocyte biology. World J Nephrol. 2:1–10. 2013. View Article : Google Scholar
|
|
41
|
Shi Y, Gao Y, Wang T, Wang X, He J, Xu J,
Wu B and Li Y: Ginsenoside rg1 alleviates podocyte EMT passage by
regulating AKT/GSK3 β/β-Catenin pathway by restoring autophagic
activity. Evid Based Complement Alternat Med. 30:19036272020.
|
|
42
|
Xing L, Liu Q, Fu S, Li S, Yang L, Liu S,
Hao J, Yu L and Duan H: PTEN inhibits high glucose-induced
phenotypic transition in podocytes. J Cell Biochem. 116:1776–1784.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mir H, Kapur N, Gales DN, Sharma PK,
Oprea-Ilies G, Johnson AT, Singh R and Singh S: CXCR6-CXCL16 axis
promotes breast cancer by inducing oncogenic signaling. Cancers
(Basel). 13:35682021. View Article : Google Scholar : PubMed/NCBI
|
